Rainier, several of are concerned about the health of the market, especially with interest rate and pre-emptive Y2K related selling concerns & preparations for defensive action. I've taken some cash off the table, locking in some good gains - to my own hurt so far. Problem is that my picks are working well now. For example, not only has ADIC & PTIX stomped, but VICL & ISIP are finally getting respect and have a good chance of additional good clinical news this fall.
I'm expecting TRIBY and PERL to increase after their next qtrs, plus TRIBY should have some product announcements, with a potential blockbuster late this year.
QSND should finally show some real profits.
Obviously all are vulnerable to not only a broad market decline, but a return of a "fright to quality" mindset.
Any reflections on holding based on good market segment performance (biotech, computer networking and storage are all working well now) vs preserving capital when you are convinced that the best the market will do the rest of the year is lose 5%? Scott
BTW, Rainier recently remarked about not selling stocks setting new highs, but watching MAs (Rainier, would a 5/20 crossover be too long a time period in cases like these?)
Here's an article that gives a good sense of why not to sell
PTIX, ADIC or TTP in this kind of market.
cbs.marketwatch.com |
